Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC). [2011 ASCO poster]
Year: 2011
Type: conference-paper
Authors: Paul Lorigan, Robert M. Jotte, Joachim von Pawel, David R. Spigel, Mark A. Socinski, Mary O’Brien, Eugene Paschold, J. Mezger, Martin Steins, Lionel Bosquée, Jeffrey A. Bubis, K. Nackaerts, JE PEREZ, P. Clingan, Wolfgang Schuette, Martin Reck, Manuel Dómine, Frances A. Shepherd, R. McNally, Markus F. Renschler
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3004428134